共 37 条
[1]
White RH(2003)The epidemiology of venous thromboembolism Circulation 107 I-4-I-8
[2]
Lyman GH(2015)Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014 J Clin Oncol 33 654-656
[3]
Bohlke K(2003)Venous thromboembolism and cancer: risks and outcomes Circulation 107 I-17-I-21
[4]
Khorana AA(2010)Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy Thromb Haemost 104 1049-68
[5]
Lee AY(2006)Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 60-1072
[6]
Levine MN(2006)Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer Am J Med 119 1062-153
[7]
Di Nisio M(2003)Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 146-1297
[8]
Ferrante N(2012)Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 2012 1287-2510
[9]
De Tursi M(2010)Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 2010 2499-694
[10]
Stein PD(2005)Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 692-e46